| EZH2 |
Primary Myelofibrosis |
disease |
Neoplastic Process |
0.32 |
DisGeNET |
| EZH2 |
Malignant neoplasm of breast |
disease |
Neoplastic Process |
0.40 |
DisGeNET |
| EZH2 |
Craniosynostosis |
disease |
Disease or Syndrome |
0.30 |
DisGeNET |
| EZH2 |
Cytopenia |
phenotype |
Pathologic Function |
0.30 |
DisGeNET |
| EZH2 |
Endometrial Neoplasms |
group |
Neoplastic Process |
0.30 |
DisGeNET |
| EZH2 |
Leukemia, Myelomonocytic, Chronic |
disease |
Neoplastic Process |
0.32 |
DisGeNET |
| EZH2 |
Lymphoma |
group |
Neoplastic Process |
0.50 |
DisGeNET |
| EZH2 |
Lymphoma, Follicular |
disease |
Neoplastic Process |
0.60 |
DisGeNET |
| EZH2 |
Osteosarcoma |
disease |
Neoplastic Process |
0.34 |
DisGeNET |
| EZH2 |
Acrocephaly |
disease |
Congenital Abnormality |
0.30 |
DisGeNET |
| EZH2 |
Prostatic Neoplasms |
group |
Neoplastic Process |
0.40 |
DisGeNET |
| EZH2 |
B-Cell Lymphomas |
group |
Neoplastic Process |
0.40 |
DisGeNET |
| EZH2 |
Diffuse Large B-Cell Lymphoma |
disease |
Neoplastic Process |
0.70 |
DisGeNET |
| EZH2 |
Lymphoma, Large-Cell, Follicular |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| EZH2 |
Lymphoma, Mixed-Cell, Follicular |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| EZH2 |
Lymphoma, Small Cleaved-Cell, Follicular |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| EZH2 |
Congenital anemia |
disease |
Disease or Syndrome |
0.30 |
DisGeNET |
| EZH2 |
Weaver-Like Syndrome |
disease |
Disease or Syndrome |
0.30 |
DisGeNET |
| EZH2 |
Brachycephaly |
disease |
Congenital Abnormality |
0.30 |
DisGeNET |
| EZH2 |
Weaver syndrome |
disease |
Disease or Syndrome |
0.78 |
DisGeNET |
| EZH2 |
Scaphycephaly |
disease |
Congenital Abnormality |
0.30 |
DisGeNET |
| EZH2 |
Trigonocephaly |
disease |
Congenital Abnormality |
0.30 |
DisGeNET |
| EZH2 |
Solid Neoplasm |
phenotype |
Neoplastic Process |
0.37 |
DisGeNET |
| EZH2 |
Juvenile Myelomonocytic Leukemia |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| EZH2 |
Malignant neoplasm of prostate |
disease |
Neoplastic Process |
0.40 |
DisGeNET |
| EZH2 |
Endometrial Carcinoma |
disease |
Neoplastic Process |
0.32 |
DisGeNET |
| EZH2 |
Breast Carcinoma |
disease |
Neoplastic Process |
0.40 |
DisGeNET |
| EZH2 |
Upper Extremity Deformities, Congenital |
group |
Congenital Abnormality |
0.30 |
DisGeNET |
| EZH2 |
Mammary Neoplasms, Human |
group |
Neoplastic Process |
0.30 |
DisGeNET |
| EZH2 |
Myelodysplastic-Myeloproliferative Diseases |
group |
Neoplastic Process |
0.30 |
DisGeNET |
| EZH2 |
Adult Diffuse Large B-Cell Lymphoma |
disease |
Neoplastic Process |
0.31 |
DisGeNET |
| EZH2 |
Childhood Diffuse Large B-Cell Lymphoma |
disease |
Neoplastic Process |
0.31 |
DisGeNET |
| EZH2 |
Mammary Neoplasms |
group |
Neoplastic Process |
0.40 |
DisGeNET |
| EZH2 |
Synostotic Posterior Plagiocephaly |
disease |
Disease or Syndrome |
0.30 |
DisGeNET |
| EZH2 |
Leukemia, Megakaryoblastic, of Down Syndrome |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| EZH2 |
Metopic synostosis |
disease |
Congenital Abnormality |
0.30 |
DisGeNET |
| EZH2 |
Lymphoma, Follicular, Grade 1 |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| EZH2 |
Lymphoma, Follicular, Grade 3 |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| EZH2 |
Lymphoma, Follicular, Grade 2 |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| EZH2 |
Hematopoetic Myelodysplasia |
disease |
Pathologic Function |
0.30 |
DisGeNET |
| EZH2 |
Synostotic Anterior Plagiocephaly |
disease |
Congenital Abnormality; Disease or Syndrome |
0.30 |
DisGeNET |
| EZH2 |
MYELODYSPLASTIC SYNDROME |
group |
Neoplastic Process |
0.40 |
DisGeNET |
| EZH2 |
Intellectual Disability |
group |
Mental or Behavioral Dysfunction |
0.41 |
DisGeNET |